K

Kyungdong Pharm
KOSDAQ:011040

Watchlist Manager
Kyungdong Pharm
KOSDAQ:011040
Watchlist
Price: 5 770 KRW 0.87% Market Closed
Market Cap: 155.8B KRW

Net Margin
Kyungdong Pharm

4.3%
Current
-0.5%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.3%
=
Net Income
8.3B
/
Revenue
193.6B

Net Margin Across Competitors

No Stocks Found

Kyungdong Pharm
Glance View

Market Cap
155.6B KRW
Industry
Pharmaceuticals

KYUNG DONG PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of medicines for liver therapy, gastrointestinal, antimigrain, osteoporosis, cardiovascular, antiviral, antiobesity, muscle relaxant, neuropathic, antibacterial, antidiabetic, central nervous system, antifungal, urology, antispasmodic, pain and inflammation, antihistamine, vitamin, repiratory, antiinflammatory enzyme, respiratory and others. The company is headquartered in Hwaseong, Gyeonggi-Do. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Company’s products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. The company also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.

Kyungdong Pharm Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.3%
=
Net Income
8.3B
/
Revenue
193.6B
What is the Net Margin of Kyungdong Pharm?

Based on Kyungdong Pharm's most recent financial statements, the company has Net Margin of 4.3%.

Back to Top